> ## Content Index
> Fetch the complete content index at: https://www.theleftshift.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Axtria Acquires Conexus to Strengthen AI-Driven CRM Capabilities in Life Sciences
- URL: https://www.theleftshift.com/axtria-acquires-conexus-to-strengthen-ai-driven-crm-capabilities-in-life-sciences/
- Published: 2026-04-16T07:30:39.000Z
- Updated: 2026-04-16T07:30:39.000Z
- Description: The acquisition brings together Axtria’s agentic AI platform with Conexus’ expertise in CRM transformation across ecosystems such as Veeva Systems and Salesforce
- Author: The Left Shift Bureau
- Tags: Acquisition

Axtria has acquired Conexus Solutions, marking a significant step in its expansion into end-to-end customer relationship management ([CRM](https://www.theleftshift.com/hubspot-becomes-first-crm-to-integrate-chatgpt-for-deep-customer-insights/)) capabilities and reinforcing its push into AI-led commercialisation for the life sciences sector.

The acquisition brings together Axtria’s agentic AI platform with Conexus’ expertise in CRM transformation across ecosystems such as Veeva Systems and [Salesforce](https://www.theleftshift.com/salesforce-closes-29-000-agentforce-deals-since-launch/). The combined offering aims to create a unified layer that connects customer engagement systems with advanced, data-driven intelligence.

Axtria said the integration will help life sciences companies transition from fragmented workflows to a cohesive operating model that spans data, analytics, CRM, and field execution. This shift is expected to enhance decision-making and streamline commercial operations.

*“This acquisition is a highly strategic step in Axtria’s journey to build the most comprehensive AI-driven commercial platform for life sciences. Together, we are uniquely positioned to bridge systems of engagement with systems of intelligence,” said* [*Jassi Chadha*](https://www.linkedin.com/in/jchadha/?ref=theleftshift.com)*, Axtria President and CEO.*

The deal comes at a time when the life sciences industry faces growing challenges, including patent expiries, the rise of specialty and cell-and-gene therapies, and increasing demand from payers for outcomes-based evidence. As a result, CRM systems are evolving from transactional tools into critical operational backbones.

Conexus adds domain expertise across commercial, quality, and R&D operations, along with a certified talent base and strong relationships within major CRM platforms. Its capabilities are expected to complement Axtria’s existing AI products, including SalesIQ, CustomerIQ, MarketingIQ, and DataMAx.

*“Joining Axtria is an exciting next step for Conexus. Our clients will continue to receive the same trusted service while gaining access to Axtria’s broader capabilities,” said* [*Akshay Kapadia*](https://www.linkedin.com/in/akshaykapadia/?ref=theleftshift.com)*, Conexus Solutions Founder and CEO.* 

The combined entity is positioning itself as a full-stack provider, reflecting a broader industry shift toward unified, AI-native platforms. Axtria said it will retain Conexus’ operating culture and client relationships while scaling its capabilities globally.